Fundraising Fox
/People
Sign in

Charles Warden

Investor

Board director at Ocular Therapeutix · Former General Partner at SV Health Investors

Burlingame, California

Writes $100K – $5M checks · typically $1.5M

Find your path to Charles

124 people in our graph can introduce you to Charles.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Pravin Dugel to introduce you to Charles

You →Pravin · together at Ocular Therapeutix →Charles

Ask Jamie Chen to introduce you to Charles

You →Jamie · 11 people · together at SV Health Investors →Charles

Sign up to find every way you can get introduced to Charles

  • Your email: the people you already email who know Charles
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Charles
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Charles Warden is Chief Executive Officer and Co-Founder of Aquea Health, Inc., a medical device company he established in 2020. He also serves as Managing Director at Versant Ventures for legacy funds. Over his career, Warden has held board positions and investor roles across numerous medical technology companies spanning ophthalmology, cardiology, orthopedics, and other sectors, with exits including acquisitions by Alcon, Medtronic, Boston Scientific, and Smith & Nephew, as well as public offerings on NASDAQ.

Board director at Ocular Therapeutix

Intro paths

→

In turn, Charles can intro founders to Ocular Therapeutix's investors below.

Ocular Therapeutix's investors · 5

Agent CapitalWaltham · since 2019Ascension VenturesSaint Louis · $10M – $20M checks · since 2019Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2019SV Health InvestorsLondon · $1M – $20M checks · since 2019Top Corner CapitalBurlingame · since 2019

Co-founders at Ocular Therapeutix

ASAmarpreet Sawhney
Amarpreet SawhneyDirector

Experience

  1. Aquea Health, Inc.Chief Executive Officer, Co-Foundercurrent2020 — present
  2. Versant VenturesManaging Directorcurrent2004 — present
  3. SV Life SciencesGeneral Partner1996 — 2004

Deals · 1

Ocular TherapeutixBoard seat

via SV Health Investors · filed Mar 2019 · $37.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Network7

Alex Badamchi-Zadeh
Vice President at SV Health Investors
Charles Dunn
Principal at SV Health Investors
Christian Jung
Partner at Dementia Discovery
Darren M. Black
Partner at SV Health Investors
Dirk Landgraf
Principal at SV Health Investors
Emily Gaudiano
Associate at SV Health Investors
Eugene Hill
Chairman at SV Health Investors

Investors connected to Charles in public investor directories — a warm-intro map.

Frequently asked questions

Who is Charles Warden?
Charles Warden is Chief Executive Officer and Co-Founder of Aquea Health, Inc., a medical device company he established in 2020. He also serves as Managing Director at Versant Ventures for legacy funds. Over his career, Warden has held board positions and investor roles across numerous medical technology companies spanning ophthalmology, cardiology, orthopedics, and other sectors, with exits including acquisitions by Alcon, Medtronic, Boston Scientific, and Smith & Nephew, as well as public offerings on NASDAQ.
Where does Charles Warden work?
Charles Warden is Board director at Ocular Therapeutix.
What check size does Charles Warden write?
Charles Warden typically writes checks of $100K – $5M.
What boards does Charles Warden sit on?
Charles Warden holds tracked board seats at Ocular Therapeutix.
Where did Charles Warden go to school?
Charles Warden studied at Harvard Business School (MBA); Beloit College.

Founder mafias

Same school

Shared employers